Origin Asset Management’s Medifast MED Stock Holding History
Bought
Maintained
Sold
Other funds holding MED
RHJA
PAMS
Origin Asset Management's MED Position: Q1 2022 in Review
Origin Asset Management sold out of Medifast (MED) in Q1 2022, closing a stake of 1,343 shares — an estimated $281K sold.
Origin Asset Management first reported a position in MED in Q2 2021 and held it in 3 quarters. The position peaked at $380K in Q2 2021. 288 funds tracked by Wall St. Rank hold MED as of Q1 2022.
- Origin Asset Management reported no remaining Medifast position as of Q1 2022 after selling out during the quarter.
- Origin Asset Management sold 1,343 Medifast shares in Q1 2022, an estimated $281K.
- Origin Asset Management first reported a position in Medifast in Q2 2021 and held it in 3 quarters.
- Origin Asset Management's Medifast position peaked at $380K in Q2 2021.
- 288 funds tracked by Wall St. Rank held Medifast as of Q1 2022.
Based on Origin Asset Management's 13F filing for Q1 2022, filed 24 May 2022.